Searched for
HORIZON PHARMA THERAPEUTICS PENNSAID
Stocks in news: Waaree Energies, Kotak Bank, HDFC Bank, Strides Pharma, Persistent SystemsIndian markets showed volatility, ending nearly flat despite positive signals. Analysts note Nifty faces resistance from key moving average...- Tribute to his leadership in Blue Economy, ocean governance: Seychelles Prez on conferring 'Guardian of the Blue Horizon' title on PM ModiThe President of Seychelles, Patrick Herminie, on Sunday conferred the honorary title of "Guardian of the Blue Horizon" on Prime Minister N...
- For investors with ability – and patience to wait 3 years, not 3 months: 6 large-cap stocks with upside potential of up to 33%The interesting point about the large-cap space today is not that prices have collapsed. In most cases, they have not. The more important c...
- Quote of the day by David Swensen: "If you’re investing with a long time horizon, having an equity bias makes sense; stocks go up in the long run"David Swensen emphasised the importance of maintaining an equity bias for long-term investors, noting that stocks tend to deliver stronger ...
- Alembic Pharma gets USFDA nod for generic influenza treatment drugAlembic Pharmaceuticals has secured USFDA approval for its generic oseltamivir phosphate oral suspension, a key treatment for influenza. Th...
- Strawberry Moon 2026: Date, time, meaning and why June's full Moon will look bigger than usualStrawberry Moon 2026: Skywatchers are in for a treat as the Strawberry Moon graces the night sky on June 29, 2026. While not red, this full...
- Investing over Rs 43,000 monthly through SIPs? Here’s what an expert recommends for 20-year investment journeyA financial expert reviews a Rs 43,500 monthly SIP portfolio built for a 20-year horizon and suggests minimal changes. The key recommendati...
- Centre set to tighten oversight of pharma packaging materialsIndia is set to implement a mandatory registration for printed pharmaceutical packaging manufacturers to combat counterfeit drugs. This mov...
- Researchers finally found evidence from a region in Space where nothing is supposed to escapeA historic black hole discovery is changing how scientists explore the universe. Researchers have detected possible fingerprints of a black...
- For the first time, researchers reached a region near a Black Hole once beyond studyA powerful black hole collision has opened a new chapter in space science. Scientists used the loudest gravitational wave signal ever detec...
- Top 10 mutual funds to invest through SIP with investment horizon of 5 years. Check detailsTop SIP mutual fund performers over five years show strong wealth creation potential, with gold, infrastructure, midcap, and smallcap funds...
- India's CDMO industry set for global shift as pharma diversifies beyond China: Sai Life SciencesIndian contract manufacturers are poised for significant growth as global pharmaceutical giants diversify away from China. Companies like S...
- Missed the FII U-turn? 6 stocks turned multibagger after foreign investors corrected their mistakeForeign institutional investors (FIIs) reversed their selling trend in six select Indian stocks, turning them into multibaggers. Bajaj Cons...
- Honasa Consumer to buy 58% stake in Fluence Pharma at Rs 135-crore enterprise valueMamaearth's parent company, Honasa Consumer, is acquiring a majority stake in nutraceuticals brand Fluence Pharma for ₹135 crore. This stra...
- Honasa Consumer enters nutraceuticals segment; to acquires 58 pc stake in Fluence PharmaHonasa Consumer, parent of Mamaearth, is acquiring a 58% stake in nutraceuticals firm Fluence Pharma for Rs 135 crore, marking its entry in...
- Biosimilars and innovation will drive Indian pharma's next growth phase: Vishal ManchandaIndia's pharmaceutical sector is pivoting beyond generics, with companies aggressively pursuing growth in biosimilars, nutraceuticals, and ...
- Smallcap funds beat all equity mutual fund categories over 3 months. Should investors change SIP strategy?Smallcap funds have emerged as the best-performing equity mutual fund category over the last three months, delivering an average return of ...
- 16 fixed-dose combination drugs banned in India: Check full list hereFixed dose combination banned full list: India has banned 16 fixed-dose combination drugs, including certain antibiotics and antispasmodics...
- India bans 16 fixed-dose drug combinations over safety concernsIn a significant public health initiative, the ban on 16 fixed-dose drug combinations, including various antibiotics and topical formulatio...
- Horizon Reclaim shares list at 47% premium over IPO price on BSE SME platformHorizon Reclaim (India) debuted on the BSE SME platform with a 46.6% premium, listing at Rs 151 against its IPO price of Rs 103. The Rs 54....
Load More
